Patients (n = 32) | Control group (n = 25) | p | |
---|---|---|---|
Age (years) | 7.5 (3.25-13) | 8 (5-9.5) | 0.881 |
Female gender (n, %) | 19 (59.4%) | 9 (36%) | 0.082 |
Phosphorus (mg/dL) | 4.9 ± 0.89 | 5 ± 0.76 | 0.561 |
Creatinine (mg/dL) | 0.53 ± 0.23 | 0.4 ± 0.13 | 0.031 |
TPR (%) | 94.6 ± 3.98 | 94.3 ± 2.66 | 0.213 |
ACR (mg/g) | 11.4 (4.6-23.72) | 6.35 (2.92-10.9) | 0.037 |
Protein-to creatinine ratio | 0.18 (0.12-0.33) | 0.15 (0.11-0.18) | 0.511 |
GFR (mL/min/1.73 m2) | 140.6 ± 28.33 | 175.8 ± 29.69 | 0.000 |
Urine netrin-1(pg/mg creatinine) | 0.26 (0.13-0.55) | 0.14 (0.11-0.21) | 0.041 |
Urine hepcidin (ng/mg creatinine) | 0.35 (0.26-0.67) | 0.45 (0.25-0.56) | 0.502 |
Urine MCP-1/CCL-2 (pg/mg creatinine) | 0.13 (0.04-0.33) | 0.08 (0.03- 0.24) | 0.543 |
Urine NGAL (ng/mg creatinine) | 0.2 (0.13-0.36) | 0.22 (0.13-0.35) | 0.672 |
Odds ratio | 95% CI | p | |
---|---|---|---|
Serum creatinine | 0.539 | 0.304 - 1.690 | 0.487 |
eGFR | 0.748 | 0.618 - 0.999 | 0.867 |
Netrin-1 | 1.423 | 1.243 - 4.823 | 0.037 |
Hepcidin | 0.568 | 0.849 - 3.663 | 0.128 |
MCP-1/CCL-2 | 1.553 | 1.386 - 6.432 | 0.033 |
NGAL | 2.112 | 2.105 - 8.225 | 0.027 |